Literature DB >> 21856301

Characterization of benzoxaborole-based antifungal resistance mutations demonstrates that editing depends on electrostatic stabilization of the leucyl-tRNA synthetase editing cap.

Jaya Sarkar1, Weimin Mao, Tommie L Lincecum, M R K Alley, Susan A Martinis.   

Abstract

The broad-spectrum benzoxaborole antifungal AN2690 blocks protein synthesis by inhibiting leucyl-tRNA synthetase (LeuRS) via a novel oxaborole tRNA trapping mechanism in the editing site. Herein, one set of resistance mutations is at Asp487 outside the LeuRS hydrolytic editing pocket, in a region of unknown function. It is located within a eukaryote/archaea specific insert I4, which forms part of a cap over a benzoxaborole-AMP that is bound in the LeuRS CP1 domain editing active site. Mutational and biochemical analysis at Asp487 identified a salt bridge between Asp487 and Arg316 in the hinge region of the I4 cap of yeast LeuRS that is critical for tRNA deacylation. We hypothesize that this electrostatic interaction stabilizes the cap during binding of the editing substrate for hydrolysis.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856301      PMCID: PMC3225056          DOI: 10.1016/j.febslet.2011.08.010

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  A conserved threonine within Escherichia coli leucyl-tRNA synthetase prevents hydrolytic editing of leucyl-tRNALeu.

Authors:  R S Mursinna; T L Lincecum; S A Martinis
Journal:  Biochemistry       Date:  2001-05-08       Impact factor: 3.162

2.  Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetase.

Authors:  Tommie L Lincecum; Michael Tukalo; Anna Yaremchuk; Richard S Mursinna; Amy M Williams; Brian S Sproat; Wendy Van Den Eynde; Andreas Link; Serge Van Calenbergh; Morten Grøtli; Susan A Martinis; Stephen Cusack
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

3.  Defects in transient tRNA translocation bypass tRNA synthetase quality control mechanisms.

Authors:  Rachel A Hellmann; Susan A Martinis
Journal:  J Biol Chem       Date:  2009-03-03       Impact factor: 5.157

Review 4.  Universal rules and idiosyncratic features in tRNA identity.

Authors:  R Giegé; M Sissler; C Florentz
Journal:  Nucleic Acids Res       Date:  1998-11-15       Impact factor: 16.971

Review 5.  Aminoacyl tRNA synthetases as targets for new anti-infectives.

Authors:  P Schimmel; J Tao; J Hill
Journal:  FASEB J       Date:  1998-12       Impact factor: 5.191

6.  The anticodon loop is a major identity determinant of Saccharomyces cerevisiae tRNA(Leu).

Authors:  A Soma; R Kumagai; K Nishikawa; H Himeno
Journal:  J Mol Biol       Date:  1996-11-15       Impact factor: 5.469

7.  Evidence for dispensable sequences inserted into a nucleotide fold.

Authors:  R M Starzyk; T A Webster; P Schimmel
Journal:  Science       Date:  1987-09-25       Impact factor: 47.728

8.  Identification of essential domains for Escherichia coli tRNA(leu) aminoacylation and amino acid editing using minimalist RNA molecules.

Authors:  Deana C Larkin; Amy M Williams; Susan A Martinis; George E Fox
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

9.  Editing mechanisms in protein synthesis. Rejection of valine by the isoleucyl-tRNA synthetase.

Authors:  A R Fersht
Journal:  Biochemistry       Date:  1977-03-08       Impact factor: 3.162

10.  An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site.

Authors:  Fernando L Rock; Weimin Mao; Anya Yaremchuk; Mikhail Tukalo; Thibaut Crépin; Huchen Zhou; Yong-Kang Zhang; Vincent Hernandez; Tsutomu Akama; Stephen J Baker; Jacob J Plattner; Lucy Shapiro; Susan A Martinis; Stephen J Benkovic; Stephen Cusack; M R K Alley
Journal:  Science       Date:  2007-06-22       Impact factor: 47.728

View more
  7 in total

1.  Exploiting evolutionary trade-offs for posttreatment management of drug-resistant populations.

Authors:  Sergey V Melnikov; David L Stevens; Xian Fu; Hui Si Kwok; Jin-Tao Zhang; Yue Shen; Jeffery Sabina; Kevin Lee; Harry Lee; Dieter Söll
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-13       Impact factor: 11.205

Review 2.  Recent development of leucyl-tRNA synthetase inhibitors as antimicrobial agents.

Authors:  Panpan Zhang; Shutao Ma
Journal:  Medchemcomm       Date:  2019-05-27       Impact factor: 3.597

3.  In Vitro Resistance and Evolution of Resistance to Tavaborole in Trichophyton rubrum.

Authors:  Diletta Mazzantini; Francesco Celandroni; Marco Calvigioni; Antonella Lupetti; Emilia Ghelardi
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

4.  Antibacterial Activity and Mode of Action of a Sulfonamide-Based Class of Oxaborole Leucyl-tRNA-Synthetase Inhibitors.

Authors:  Yuanyuan Si; Sneha Basak; Yong Li; Jonathan Merino; James N Iuliano; Stephen G Walker; Peter J Tonge
Journal:  ACS Infect Dis       Date:  2019-05-01       Impact factor: 5.084

Review 5.  tRNAs as antibiotic targets.

Authors:  Shaileja Chopra; John Reader
Journal:  Int J Mol Sci       Date:  2014-12-25       Impact factor: 5.923

Review 6.  A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis.

Authors:  S E Dmitriev; D O Vladimirov; K A Lashkevich
Journal:  Biochemistry (Mosc)       Date:  2020-11       Impact factor: 2.487

7.  Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance.

Authors:  Sabine Ottilie; Madeline R Luth; Erich Hellemann; Gregory M Goldgof; Eddy Vigil; Prianka Kumar; Andrea L Cheung; Miranda Song; Karla P Godinez-Macias; Krypton Carolino; Jennifer Yang; Gisel Lopez; Matthew Abraham; Maureen Tarsio; Emmanuelle LeBlanc; Luke Whitesell; Jake Schenken; Felicia Gunawan; Reysha Patel; Joshua Smith; Melissa S Love; Roy M Williams; Case W McNamara; William H Gerwick; Trey Ideker; Yo Suzuki; Dyann F Wirth; Amanda K Lukens; Patricia M Kane; Leah E Cowen; Jacob D Durrant; Elizabeth A Winzeler
Journal:  Commun Biol       Date:  2022-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.